From brink of bankruptcy to boom

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Garren Hillow, Executive Coach and Author.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Garren, covering:

• Why not being a PhD scientist really helped him in selling science
• How recruiting for glory enabled him to hire the best people on the planet
• Buying a CRO business and getting comfortable with the risk of bankruptcy
• Going all in on his business, and sticking true to its core vision, enabled this David to beat the sector's Goliaths
• From struggling to make payroll, to the perfect storm that led to a $190m sale

Garren Hilow is a biotech entrepreneur, advisor, and speaker best known for co-founding Abveris, an antibody discovery company he scaled without venture capital and ultimately sold to Twist Bioscience for $ 190 M. His journey is a masterclass in building a high-value, capital-efficient business in one of the world’s toughest industries. At Abveris, Garren focused on resourcefulness, sales mastery, and building a sellable system, not just a company, allowing him to achieve a major exit while staying true to his entrepreneurial ideals.

Today, Garren works with founders and CEOs across life sciences and B2B sectors, helping them build scalable, independent businesses without sacrificing control. He’s passionate about empowering entrepreneurs to create long-term value through practical skills like sales, leadership, and strategic marketing, always with an eye on sustainable, founder-friendly growth.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! 

Molecule to Market is also sponsored and funded by  ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.